Close Menu

NEW YORK – BGI Americas said this week it that has received authorization from Health Canada under an interim order to market its Real-Time Fluorescent RT-PCR kit for SARS-CoV-2 detection in Canada. The kit is part of an integrated solution that includes MGI's MGIEasy Nucleic Acid Extraction Kit, which is included as a validated method for RNA extraction in the authorization, and the MGISP-960RS Automated Sample Preparation System.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.